- Most Americans Want to End Seasonal Time Changes: Survey
- Coronavirus in a Cough: Tests Show Masks Stopping the Spread
- Politics Key to Americans’ Views on COVID-19, Poll Shows
- U.S. Daily COVID Case Count Nears Record for Pandemic
- Health Highlights: Oct. 23, 2020
- COVID-19 More Common in Pregnant Hispanics Than Other Moms-to-Be: Study
- Homeless More Likely to Die After Heart Attack
- More Than Half of Americans Know Someone Infected or Ill With COVID: Poll
- CDC Broadens Definition of ‘Close Contact’ in Tracing COVID Infections
- Health Highlights: Oct. 22, 2020
Clinical Trials Update: Dec. 15, 2009
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Depression
This study seeks people diagnosed with depression that have not fully responded to an antidepressant medication. The study will evaluate newly developed brain imaging methods that will allow participants to help control brain activation.
The research site is in Menlo Park, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Type 2 Diabetes (Metformin Users)
This study will evaluate the safety and tolerability of an investigational medication for type 2 diabetes. Participants will take daily capsules of the investigational drug along with their usual dose of Metformin.
The research site is in High Point, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Metastatic Colorectal Cancer – PEAK Study
This study is for people with colorectal cancer that has metastasized (spread). The study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it extends survival.
The research site is in Indianapolis, Ind.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/colorectal_cancer.aspx.
—–
Copyright 2009 ClinicalConnection.com. All rights reserved.
Source: HealthDay
